Skip to main content
OpenTrials

Clinical trial condition

Hypersensitivity

Explore clinical trials studying Hypersensitivity. Study availability and eligibility vary by location and protocol.

6,786 public trials 654 recruiting studies
Refine in advanced search Browse all conditions

Hypersensitivity trial results

Completed

Open-Label Extension Study for Subjects With H1 Antihistamine Refractory Chronic Spontaneous Urticaria Completing Study AK006-001

NCT06577116

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +10 more
Locations
  • Site 601-004 Birmingham, Alabama, United States
  • Site 601-014 Bakersfield, California, United States
  • Site 601-015 Upland, California, United States
  • Site 601-006 Overland Park, Kansas, United States
View all 14 locations
View Trial Details
Completed

Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of EP262 in Subjects With Atopic Dermatitis

NCT06144424

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Allervie Clinical Research Birmingham, Alabama, United States
  • RM Medical Research, Inc. Miami Lakes, Florida, United States
  • Indiana Clinical Trials Center Plainfield, Indiana, United States
  • Lawrence J. Green, MD LLC Rockville, Maryland, United States
View Trial Details
Completed

Dupilumab for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine and Who Are naïve to, Intolerant of, or Incomplete Responders to Omalizumab (LIBERTY-CSU CUPID)

NCT04180488

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +10 more
Locations
  • California Allergy and Asthma Medical Group, Inc. Site Number : 8400019 Los Angeles, California, United States
  • Sarasota Clinical Research Site Number : 8400017 Sarasota, Florida, United States
  • Lenus Research & Medical Group Site Number : 8400001 Sweetwater, Florida, United States
  • University of South Florida Site Number : 8400006 Tampa, Florida, United States
View all 98 locations
View Trial Details
Completed

An Observational Study of Upadacitinib to Assess Change in Disease Activity in Canadian Adult Participants With Moderate-to-Severe Atopic Dermatitis Who Are Inadequate Responders To or Discontinuing Dupilumab

NCT05394792

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Dermatology Research Institute - Blackfoot Trail /ID# 246344 Calgary, Alberta, Canada
  • Laser Rejuvenation Clinics Inc. /ID# 255303 Calgary, Alberta, Canada
  • Rejuvenation Dermatology Clinic Calgary North /ID# 255623 Calgary, Alberta, Canada
  • Rejuvenation Dermatology - Edmonton Downtown /ID# 246298 Edmonton, Alberta, Canada
View all 25 locations
View Trial Details
Completed

An Efficacy and Safety Study of GNR-086 (Canakinumab Biosimilar) and Ilaris® in Patients With Adult-onset Still's Disease

NCT06497491

Conditions
Arthritis, Hypersensitivity, Immune System Diseases, +6 more
Locations
  • State budgetary healthcare institution "Chelyabinsk Regional Clinical Hospital" Chelyabinsk, Chelyabinsk Oblast, Russia
  • Limited Liability Company "Medical Center "Revma-Med" Kemerovo, Kemerovo Oblast, Russia
  • Limited Liability Company "OLLA-MED" Moscow, Russia
  • Federal State Budgetary Institution "Research Institute of Rheumatology named after V.A. Nasonova" Moscow, Russia
View all 17 locations
View Trial Details

Related conditions